However, an analysis performed separately on the samples from healthy controls and lower-risk IPSS-R patients identified a moderate correlation of H19 expression with both IGF2 (r = 0.321, p = 0.034) and miR-675 (r = 0.342, p = 0.023), whereas this concordance was disturbed in intermediate/higher-risk MDS (Figure 5B). The gene discussed is IGF2; the disease is myelodysplastic syndrome.